ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,890 | -40.6% | 52,354 | 0.0% | 0.00% | – |
| Q1 2023 | $18,324 | -17.8% | 52,354 | -50.0% | 0.00% | – |
| Q4 2022 | $22,302 | +23.9% | 104,708 | +100.0% | 0.00% | – |
| Q3 2022 | $18,000 | -74.3% | 52,354 | 0.0% | 0.00% | – |
| Q2 2022 | $70,000 | -33.3% | 52,354 | 0.0% | 0.00% | – |
| Q1 2022 | $105,000 | -22.2% | 52,354 | +4.4% | 0.00% | – |
| Q4 2021 | $135,000 | -37.2% | 50,154 | 0.0% | 0.00% | – |
| Q3 2021 | $215,000 | +72.0% | 50,154 | +2.5% | 0.00% | – |
| Q2 2021 | $125,000 | – | 48,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 38,982 | $200,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 802 | $5,000 | 0.00% |
| UBS Group AG | 2,723 | $14,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11,775 | $60,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 250 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,162 | $138,000 | 0.00% |
| MORGAN STANLEY | 545 | $3,000 | 0.00% |
| BlackRock Inc. | 205,684 | $1,053,000 | 0.00% |